I Just Added This Stock to My Shopping List Amid Sluggish Market Action
With poor seasonality and bond worries weighing on stocks, the job is to protect capital and build a shopping list.
Raising Cash by Selling From These 2 Small-Cap Positions
Despite these planned sales, we’re not making a statement about the stocks involved.
Jackson Hole and Nvidia Loom, but Don’t Forget the Elephant in the Room
Will things get a little wild this week? Plus a look a close look at gold, the Utes and two potential tax-loss selling candidates.
Bearish Bets: 3 Big Retailers, 3 Big Earnings Fails
The stocks of these three retailers are in trouble after reporting quarterly results.
Making a Small Bet on an Electric Grid Buildout Play
This covered-call strategy has 25% upside potential as the data center buildout calls for juice.
After Moderna’s Big News, Here Are Three Biotechs to Watch
I’m following these lesser-known names amid biopharma’s move on Wednesday.
The $40 Trillion Reason Bitcoin Woke Up
Here’s what caused the rally (and what didn’t) — and where Bitcoin faces its next test.
Are Complacent Investors Setting the Market Up for a Fast and Furious Decline?
The market is down, but investors aren’t scared. Does that mean there’s more downside to come?
Moderna Leads the Charge as Pharma ETF Hits All-Time High
Tempus AI and Merck are key contributors to Moderna’s success.
Bonds Rallied. Stocks Rallied. Just Not In the Way We Like.
Defensive issues took the lead. Does that mean we could be in for more downside?